Qiagen N.V. (QGEN) is in Healthcare, Diagnostics & Research, based in Netherlands, listed on NYSE. Market cap 9.20B USD. 52-week range 32.53 to 57.82 USD. Trailing P/E 22.6. Data as of 2026-10-09.
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of ...